Insurance type influences the use of drug-eluting stents.
Gaglia MA Jr, Torguson R, Xue Z, Gonzalez MA, Collins SD, Ben-Dor I, Syed AI, Maluenda G, Delhaye C, Hanna N, Wakabayashi K, Kaneshige K, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.
Gaglia MA Jr, et al. Among authors: delhaye c.
JACC Cardiovasc Interv. 2010 Jul;3(7):773-9. doi: 10.1016/j.jcin.2010.04.011.
JACC Cardiovasc Interv. 2010.
PMID: 20650440
Free article.